Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Reneo Pharmaceuticals Inc RPHM

Healthcare Biotechnology
Reneo Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The Company's product candidate, mavodelpar, is a potent and selective agonist of the peroxisome... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RPHM)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPHM, WIRE, BCAL, AIRC

PR Newswire 5 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBOW, PRFT, RPHM

PR Newswire 8 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALE, RPHM, AGS

PR Newswire 12 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPHM, ALE, HRT

Accesswire 13 days ago

SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SQSP, RPHM, ALE, HRT

Accesswire 13 days ago

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

Business Wire 13 days ago

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM

PR Newswire May 13, 2024

Lifshitz Law PLLC Announces Investigations of RPHM, SQSP, AGS, and LSAK

Accesswire May 13, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Reneo Pharmaceuticals, Inc. Merger

Newsfile May 13, 2024
View More News ››

Opinion & Analysis (NDAQ:RPHM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RPHM)

Be the first to post on this bullboard.

Anfield Energy Inc

Anfield Energy Inc

Anfield Energy Inc. is a Canada-based uranium and vanadium development and near-term production company. A key asset in the ...
View More »